Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
25 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
89/100
Trial Completion Rate
72/100
Pipeline Concentration
20/100
Pipeline Freshness
72/100
Strategic Signals
Activity
Last 14 days
Digital Shared Decision-Making Aid to Improve Patient-Centered Outcomes in Implantable Cardioverter-Defibrillator (ICD) Decisions Among Older Patients, ENHANCE-ICD (SU sIRB)
Confluence of Sleep, Circadian Rhythms, and the Menstrual Cycle on Injury Risk in Women
Pilot Intervention for Parents of Psychiatrically-Hospitalized Youth
Vagus Nerve Stimulation (VNS) Electroencephalogram (EEG) Protocol Supplement
Behavioral and Neuronal Correlates of Human Mood States
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
ASPIRE to Change: Leveraging Text Messaging Peer Support Coaching to Mitigate Hazardous Alcohol Consumption in Non-Collegiate Young Adults
Using Short Animated Storytelling to Increase Intent for Colorectal Cancer Screening: A U.S. Online Randomized Controlled Trial
Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry Guided Breathing Therapy
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)